Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research - Dorward, J; Lessells, R; Drain, P; Naidoo, K; De Oliveira, T; Pillay, Y; Abdool Karim, S; Garrett, N (Lancet HIV, 2018)